Nicotinamide mononucleotide enhances the efficacy and persistence of CD19 CAR-T cells via NAD + –Sirt1 axis
Zhen Yu(Capital Medical University), Xiaosong Zhong(Capital Medical University)
Cited by 3
Related Papers
Co-expression IL-15 receptor alpha with IL-15 reduces toxicity via limiting IL-15 systemic exposure during CAR-T immunotherapy
|Journal of Translational Medicine|2022|45
IL13Rα2-targeted third-generation CAR-T cells with CD28 transmembrane domain mediate the best anti-glioblastoma efficacy
|Cancer Immunology Immunotherapy|2023|16
Gastrodin synergistically increases migration of interleukin‐13 receptor α2 chimeric antigen receptor T cell to the brain against glioblastoma multiforme: A preclinical study
|Phytotherapy Research|2023|4
IL-15 receptor alpha reduces the toxicity of IL-15 during CAR-T immunotherapy
|Research Square|2022|0